Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases

Literature DB >> 22846894

Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases - a systematic review.

Timothy X Yang¹, Terence C Chua, David L Morris.

Abstract

This review examines the clinical efficacy and safety of the use of hepatic arterial chemoembolization, bland embolization and radioembolization in the treatment of unresectable neuroendocrine tumor liver metastases (NETLM). Response to treatment, survival outcome and toxicity were examined in this review of 37 studies comprising 1575 patients. These therapies are safe and effective in the treatment of NETLM. Prospective clinical trials to compare the relative efficacy and toxicity are warranted.

Entities: Disease Species

Mesh：

Year: 2012 PMID： 22846894 DOI： 10.1016/j.suronc.2012.07.001

Source DB: PubMed Journal: Surg Oncol ISSN： 0960-7404 Impact factor: 3.279

Keyword Cloud
Cited

29 in total

1. Outcomes After Transarterial Embolization of Neuroendocrine Tumor Liver Metastases Using Spherical Particles of Different Sizes.

Authors: Rebecca Zener; Hyukjun Yoon; Etay Ziv; Anne Covey; Karen T Brown; Constantinos T Sofocleous; Raymond H Thornton; F Edward Boas
Journal: Cardiovasc Intervent Radiol Date: 2019-01-09 Impact factor: 2.740

Review 2. Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.

Authors: Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal: Expert Opin Pharmacother Date: 2016-09-23 Impact factor: 3.889

Review 3. Radioembolization of hepatic tumors.

Authors: Andrew Kennedy
Journal: J Gastrointest Oncol Date: 2014-06

4. Clinical Interventional Oncology Symposium And Integrative Healthcare Symposium.

Authors: Walter Alexander
Journal: P T Date: 2017-04

5. CT evaluation of response in advanced gastroenteropancreatic neuroendocrine tumors treated with long-acting-repeatable octreotide: what is the optimal size variation threshold?

Authors: Yanji Luo; Jie Chen; Bingqi Shen; Meng Wang; Huasong Cai; Ling Xu; Luohai Chen; Minhu Chen; Zi-Ping Li; Shi-Ting Feng
Journal: Eur Radiol Date: 2018-06-06 Impact factor: 5.315

Radioembolization and chemoembolization for unresectable neuroendocrine liver metastases - a systematic review.

1. Outcomes After Transarterial Embolization of Neuroendocrine Tumor Liver Metastases Using Spherical Particles of Different Sizes.

Review 2. Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.

Review 3. Radioembolization of hepatic tumors.

4. Clinical Interventional Oncology Symposium And Integrative Healthcare Symposium.

5. CT evaluation of response in advanced gastroenteropancreatic neuroendocrine tumors treated with long-acting-repeatable octreotide: what is the optimal size variation threshold?

6. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.

7. Role of liver ICAM-1 in metastasis.

Review 8. Carcinoid-syndrome: recent advances, current status and controversies.

Review 9. Isolated hepatic perfusion for patients with liver metastases.

Review 10. Liver transarterial embolizations in metastatic neuroendocrine tumors.